Xenetic Biosciences Inc (XBIO) — Capital Reinvestment Ratio

Latest as of December 2017: 0.00x

Xenetic Biosciences Inc (XBIO) has a Capital Reinvestment Ratio of 0.00x as of December 2017, meaning it reinvests 0% of its operating cash flow ($4.84 Million) in capital expenditures ($9.00K). Check Xenetic Biosciences Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$4.84 Million
USD

Capital Expenditures

$9.00K
USD

Data as of

Dec 2017
Most recent filing

Xenetic Biosciences Inc Capital Reinvestment Ratio (2017–2017)

This chart tracks Xenetic Biosciences Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see XBIO cash flow metrics.

Annual Capital Reinvestment Ratio for Xenetic Biosciences Inc (2017–2017)

Year-by-year Capital Reinvestment Ratio for Xenetic Biosciences Inc from 2017 to 2017. See Xenetic Biosciences Inc (XBIO) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2017 0.01x $1.49 Million $9.26K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow